Oakville, Ontario–(Newsfile Corp. – June 12, 2025) – Xediton Pharmaceuticals Inc. is proud to announce that Vabomere® (meropenem-vaborbactam) has been approved by Health Canada and is now commercially available across the country. Vabomere is indicated in adults for the treatment of complicated urinary tract infections including pyelonephritis, complicated intra-abdominal infection, …
Read More »
Breaking News
- Medaro Announces Agreement to Option Ontario Mineral Property
- Bri-Chem Corp. Letter to Shareholders
- CSE Bulletin: Expiry – Giant Mining Corp. 14JAN2026 Warrants (BFG.WT.B)
- Ravelin Properties REIT Announces Change to the Board of Trustees
- J4 Ventures Resources Corp. Announces Change in Officer
- AnalytixInsight Announces Proposed Share Consolidation
- Utah Approves AI Prescriptions Drugs. How AI Is Saving Time, Cutting Costs – and Why Molecule.ai’s Drug Discovery Platform Matters More Than Ever
- Sixty North Gold Announces Non-Brokered $1,500,000 Unit Offering
- LongPoint Announces ETF Share Splits and Consolidations
- J4 Ventures Resources Corp. Announces Grant of Stock Options
Matribhumi Samachar
Address : 125 - Rajiv Nagar, Vinayakpur, Kanpur - 208025
Mo. No.: 8303063085
Email: [email protected]
Managed By Y2KSOLUTION
Copyright © Matribhumi Samachar